Randomised Multicentre Phase IV Study to Compare Glivec (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec in Combination With Interferon Alpha at Low Doses in the Treatment of Newly-Diagnosed Chronic-Phase Chronic Myeloid Leukaemia.

Trial Profile

Randomised Multicentre Phase IV Study to Compare Glivec (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec in Combination With Interferon Alpha at Low Doses in the Treatment of Newly-Diagnosed Chronic-Phase Chronic Myeloid Leukaemia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Apr 2014

At a glance

  • Drugs Imatinib (Primary) ; Interferon alpha-2b
  • Indications Chronic myeloid leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Mar 2010 Results published in Haematologica.
    • 20 Apr 2008 Status changed from in progress to completed
    • 01 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top